AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes

Contributed by: GlobeNewswire

Tags

diabetes

More Like This

French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress

Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens

iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001

Tanner Pharma Group and Biodexa Launch Global Early Access Program for FAP Patients